Cubist Systematic Strategies’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-396,726
Closed -$3.99M 4591
2022
Q4
$3.99M Hold
396,726
0.02% 1231
2022
Q3
$3.9M Buy
396,726
+208,580
+111% +$2.05M 0.02% 1324
2022
Q2
$1.84M Buy
188,146
+72,644
+63% +$711K 0.01% 1939
2022
Q1
$1.13M Buy
115,502
+100
+0.1% +$971 0.01% 1940
2021
Q4
$1.13M Buy
+115,402
New +$1.12M 0.01% 1830

Other funds holding AONC

Cubist Systematic Strategies's AONC Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 396,726 shares — an estimated $3.99M sold.

Cubist Systematic Strategies first reported a position in AONC in Q4 2021 and held it in 5 quarters. The position peaked at $3.99M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Cubist Systematic Strategies reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 396,726 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $3.99M.
  • Cubist Systematic Strategies first reported a position in American Oncology Network, Inc. Class A Common Stock in Q4 2021 and held it in 5 quarters.
  • Cubist Systematic Strategies's American Oncology Network, Inc. Class A Common Stock position peaked at $3.99M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.